REG - Cambridge Cognition - Grant of Options

Cambridge Cognition HoldingsAnnouncement

16/11/2021 07:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211116:nRSP4406Sa&default-theme=true

RNS Number : 4406S  Cambridge Cognition Holdings PLC  16 November 2021

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

 

Grant of Options

 

Cambridge Cognition Holdings plc (AIM: COG), which develops and markets
digital solutions to assess brain health, announces that on 15 November 2021,
the Company granted options ("Options") over a total of 47,500 ordinary shares
of 1 pence each in the capital of the Company ("Ordinary Shares") pursuant to
the Company's EMI option scheme and its unapproved option scheme.

Of these Options:

1.   40,000 were granted to Persons Discharging Managerial Responsibilities
("PDMRs") on behalf of the Company;

 Name           Role                     Number of Options Granted  Total number of Options held following Grant  Total number of Ordinary Shares held  Percentage of Current Issued Share Capital Held
 Matthew Stork  Chief Executive Officer  40,000                     823,061                                       125,000                               0.40%

 

2.   7,500 were granted to other employees of the Company.

Of the Options granted:

1.   All Options granted to Matthew Stork are exercisable at a price of 140
pence per Ordinary Share from three years following the date of award until
the tenth anniversary of the date of award, subject to satisfying the
following performance criteria:

a.   50% of the Options granted will vest if the average closing mid-market
price of an Ordinary Share for any three month period exceeds 170 pence, with
the price on the last day of that period being at least 145 pence, and the
last day of this period being no later than 30 April 2024; and

b.   50% of the Options granted will vest if the average closing mid-market
price of an Ordinary Share for any three month period exceeds 220 pence, with
the price on the last day of that period being at least 170 pence, and the
last day of this period being no later than 30 April 2024.

 

2.   The remaining 7,500 options granted to employees are exercisable at a
price of 1 pence per Ordinary Share from two years following the date of award
until the tenth anniversary of the date of award. All of these Options are
granted over shares already in issue and held by Cambridge Cognition Trustees
Limited on behalf of the Employee Benefit Trust.

Following the grant of Options, the total number of Options outstanding over
unissued Ordinary Shares is 2,553,559 representing approximately 8.19% of the
Company's issued share capital.

The notification below, made in accordance with the requirements of the EU
Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

 1.            Details of the person discharging managerial responsibilities / person closely
               associated
 a)            Names                                                        Matthew Stork - Chief Executive Officer
 2.            Reason for the Notification
 a)            Position/status                                              See 1(a) above for positions - all classified as PDMRs of the Company
 b)            Initial notification/ Amendment                              Initial Notification
 3.            Details of the issuer, emission allowance market participant, auction
               platform, auctioneer or auction monitor
 a)            Name                                                         Cambridge Cognition Holdings Plc
 b)            LEI                                                          213800SZKDIN122EPA96
 4.            Details of the transaction(s): section to be repeated for (i) each type of
               instrument; (ii) each type of transaction; (iii) each date; and (iv) each
               place where transactions have been conducted
 a)            Description of the Financial instrument, type of instrument  In each case, the grant of Options over Ordinary Shares on 15 November 2021

               Identification code                                          GB00B8DV9647
 b)            Nature of the transaction                                    Grant of Options over Ordinary Shares

 c)            Price(s) and volume(s)                                       Price: n/a

                                                                            Volumes:

                                                                            Matthew Stork - 40,000 Options
 d)            Aggregated information:                                      n/a

·        Aggregated volume

               ·        Price
 e)            Date of the transaction                                      15 November 2021
 f)            Place of the transaction                                     Outside a trading venue

 

The information communicated in this announcement is inside information for
the purposes of Article 7 of EU Regulation 596/2014

Enquiries

 Cambridge Cognition Holdings PLC
 Matthew Stork, Chief Executive Officer      Tel: 01223 810 700

 Steven Powell, Chair                        press@camcog.com (mailto:press@camcog.com)

 finnCap Ltd (NOMAD and Joint Broker)        Tel: 020 7220 0500
 Geoff Nash / Simon Hicks                    (Corporate Finance)
 Alice Lane/Charlotte Sutcliffe              (Corporate Broking)

 Dowgate Capital Limited (Joint Broker)      Tel: 020 3903 7715

 David Poutney/ James Serjeant               (Corporate Broking)

 IFC Advisory Limited (Financial PR and IR)  Tel: 020 3934 6630
 Tim Metcalfe/ Graham Herring/ Zach Cohen

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHDELFFFFLBFBF